According to Viatris's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 0.854405. At the end of 2023 the company had a P/S ratio of 0.8422.
Year | P/S ratio | Change |
---|---|---|
2023 | 0.8422 | 1.48% |
2022 | 0.8299 | -9.28% |
2021 | 0.9148 | -51.68% |
2020 | 1.89 | 109.88% |
2019 | 0.9021 | -27.02% |
2018 | 1.24 | -35.15% |
2017 | 1.91 | 3.42% |
2016 | 1.84 | -34.49% |
2015 | 2.81 | 2.68% |
2014 | 2.74 | 17.38% |
2013 | 2.33 | 45.79% |
2012 | 1.60 | 7.23% |
2011 | 1.49 | -11.68% |
2010 | 1.69 | 52.43% |
2009 | 1.11 | 89.09% |
2008 | 0.5866 |
Company | P/S ratio | P/S ratio differencediff. | Country |
---|---|---|---|
OPKO Health
OPK | 1.09 | 27.54% | ๐บ๐ธ USA |
Onconova Therapeutics ONTX | 92.5 | 10,726.08% | ๐บ๐ธ USA |